These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2940340)

  • 21. [Possible disorder of tissue immunity function in mothers who have given birth to a child with Down's disease].
    Davidenkova EF; Sokolova SM; Butomo IV; Khitrikova LE; Chukhlovin AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(6):863-5. PubMed ID: 143174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining.
    Crossen PE; Morgan WF
    Hum Genet; 1980; 53(3):311-3. PubMed ID: 6154638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlative study of the brain CT and clinical features of patients with Down's syndrome in three clinical stages of Alzheimer type dementia].
    Maruyama K; Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1995 Jul; 35(7):775-80. PubMed ID: 8777802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
    Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
    Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon.
    Gurari-Rotman D; Revel M; Tartakovsky B; Segal S; Hahn T; Handzel Z; Levin S
    FEBS Lett; 1978 Oct; 94(2):187-90. PubMed ID: 151636
    [No Abstract]   [Full Text] [Related]  

  • 29. [Down syndrome: immunological study in adults (author's transl)].
    Argentiero V; Tavolato B; Bertolissi M; Gentile B; Piazza L
    Riv Patol Nerv Ment; 1979 Jun; 99(5):267-74. PubMed ID: 159484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lymphocytotoxins and lymphocyte responses to mitogens of Down syndrome person.
    Nishida Y; Akaoka I; Suzuki T; Kobayashi M; Maruki K
    Am J Ment Defic; 1981 May; 85(6):596-600. PubMed ID: 6455917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feline lymphocytes: observations on surface membrane concanavalin A receptor mobility.
    Nichols WS; Dunlap JE; Hebebrand LC; Mathes LE; Olsen RG
    Am J Vet Res; 1979 Jul; 40(7):959-61. PubMed ID: 507498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective monocyte chemotaxis in children with Down's syndrome.
    Barroeta O; Nungaray L; López-Osuna M; Armendares S; Salamanca F; Kretschmer RR
    Pediatr Res; 1983 Apr; 17(4):292-5. PubMed ID: 6222283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-microtubule interactions: concanavalin A capping induced redistribution of cytoplasmic microtubules and colchicine binding proteins.
    Albertini DF; Clark JI
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4976-80. PubMed ID: 1061084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.